IL26 and rheumatoid arthritis: Nonetheless, the authors suggest, it would be worthwhile to investigate whether interfering with IL-26 production—perhaps by introducing IL-26-blocking antibodies to affected joints early in the disease—might short-circuit RA disease progression.